Literature DB >> 22130419

Chemoproteomic approaches to drug target identification and drug profiling.

Marcus Bantscheff1, Gerard Drewes.   

Abstract

Chemoproteomics represents a new research discipline at the interface of medicinal chemistry, biochemistry, and cell biology focused on studying the molecular mechanisms of action of drugs and other bioactive small molecules. Research strategies frequently combine phenotypic screening with subsequent target identification, and aim at a proteome-wide characterization of drug-induced changes in cellular protein expression and post-translational modifications. In recent years quantitative mass spectrometry has taken center stage in many of these approaches. This review describes experimental strategies in current chemical proteomics research, discusses recent examples of successful applications, and highlights areas in drug discovery where chemical proteomics-based assays using native endogenous proteins are expected to have substantial impact. Copyright Â
© 2011. Published by Elsevier Ltd.

Mesh:

Substances:

Year:  2011        PMID: 22130419     DOI: 10.1016/j.bmc.2011.11.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  26 in total

1.  Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells.

Authors:  Claudia Ctortecka; Vinayak Palve; Brent M Kuenzi; Bin Fang; Natalia J Sumi; Victoria Izumi; Silvia Novakova; Fumi Kinose; Lily L Remsing Rix; Eric B Haura; John Matthew Koomen; Uwe Rix
Journal:  Mol Cell Proteomics       Date:  2018-09-14       Impact factor: 5.911

2.  A High-Efficiency Cellular Extraction System for Biological Proteomics.

Authors:  Avantika Dhabaria; Paolo Cifani; Casie Reed; Hanno Steen; Alex Kentsis
Journal:  J Proteome Res       Date:  2015-07-14       Impact factor: 4.466

3.  Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning.

Authors:  Bernardo Ribeiro da Cunha; Luís P Fonseca; Cecília R C Calado
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-14       Impact factor: 4.813

Review 4.  Applications of chemogenomic library screening in drug discovery.

Authors:  Lyn H Jones; Mark E Bunnage
Journal:  Nat Rev Drug Discov       Date:  2017-01-20       Impact factor: 84.694

5.  Direct identification of ligand-receptor interactions on living cells and tissues.

Authors:  Andreas P Frei; Ock-Youm Jeon; Samuel Kilcher; Hansjoerg Moest; Lisa M Henning; Christian Jost; Andreas Plückthun; Jason Mercer; Ruedi Aebersold; Erick M Carreira; Bernd Wollscheid
Journal:  Nat Biotechnol       Date:  2012-09-16       Impact factor: 54.908

6.  Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat.

Authors:  Isabelle Becher; Thilo Werner; Carola Doce; Esther A Zaal; Ina Tögel; Crystal A Khan; Anne Rueger; Marcel Muelbaier; Elsa Salzer; Celia R Berkers; Paul F Fitzpatrick; Marcus Bantscheff; Mikhail M Savitski
Journal:  Nat Chem Biol       Date:  2016-09-26       Impact factor: 15.040

Review 7.  Chemical biology approaches for the study of apicomplexan parasites.

Authors:  Matthew A Child
Journal:  Mol Biochem Parasitol       Date:  2013-12-11       Impact factor: 1.759

8.  Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

Authors:  Paul Morgan; Dean G Brown; Simon Lennard; Mark J Anderton; J Carl Barrett; Ulf Eriksson; Mark Fidock; Bengt Hamrén; Anthony Johnson; Ruth E March; James Matcham; Jerome Mettetal; David J Nicholls; Stefan Platz; Steve Rees; Michael A Snowden; Menelas N Pangalos
Journal:  Nat Rev Drug Discov       Date:  2018-01-19       Impact factor: 84.694

9.  A quantitative proteomics-based competition binding assay to characterize pITAM-protein interactions.

Authors:  Lianghai Hu; Li Yang; Andrew M Lipchik; Robert L Geahlen; Laurie L Parker; W Andy Tao
Journal:  Anal Chem       Date:  2013-05-08       Impact factor: 6.986

10.  Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.

Authors:  Chia-Chen Ko; Yun-Ju Chen; Chih-Ta Chen; Yu-Chih Liu; Fong-Chi Cheng; Kai-Chao Hsu; Lu-Ping Chow
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.